FDA Clearance Tracker · P050044-S003
VITAGEL SURGICAL HEMOSTAT
Last checked: Nov 20, 2026Latest source record: Dec 17, 2007 (this decision)Source: openFDAMethods & limitations
Decided
Dec 17, 2007
Approved
Time to decision
41 days
Received Nov 6, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P050044-S003
- Device name
- VITAGEL SURGICAL HEMOSTAT
- Applicant
- Stryker Corp.
- Applicant location
- Kalamazoo, MI
- Received
- Nov 6, 2007
- Decided
- Dec 17, 2007
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P050044
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A CONTRACT TESTING FACILITY LOCATED AT LEXAMED, TOLEDO, OHIO.
Source documents
Other decisions for Stryker Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- HipCheck510(k)
K230045 · Decided Sep 29, 2023 · 266 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
K191259 · Decided Jul 12, 2019 · 63 days after receipt
Device type: Arthroscope (HRX) · Orthopedic Surgery
- HipCheck510(k)
K182359 · Decided Dec 13, 2018 · 105 days after receipt
Device type: System, Image Processing, Radiological (LLZ) · Radiology & Imaging
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.